Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project
- PMID: 16279871
- DOI: 10.1111/j.1600-0447.2005.00633.x
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project
Abstract
Objective: To identify baseline sociodemographic and clinical factors associated with a current chronic major depressive episode (MDE).
Method: Outpatients with major depressive disorder enrolled in 41 US primary or psychiatric care sites were divided into two groups based on self-report of current episode length (<24 or > or =24 months). Logistic regression models were used to identify factors associated with chronicity of current depressive episode.
Results: About 21.2% of 1380 subjects were in current, chronic MDEs. Older age, less education, lower income, no private insurance, unemployment, greater general medical illness burden, lower physical quality of life, concurrent generalized anxiety disorder, fewer prior episodes, and history of prior suicide attempts were all associated with chronic episodes. Blacks, Hispanics, and patients receiving care in primary as opposed to psychiatric care settings exhibited greater chronicity.
Conclusion: Chronic depressive episodes are common and are associated with greater illness burden, comorbidity, socioeconomic disadvantage, and racial/ethnic minority status.
Similar articles
-
Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial.J Affect Disord. 2007 Jan;97(1-3):77-84. doi: 10.1016/j.jad.2006.05.026. Epub 2006 Jul 7. J Affect Disord. 2007. PMID: 16824617 Clinical Trial.
-
Insured and non-insured depressed outpatients: how do they compare?Ann Clin Psychiatry. 2007 Apr-Jun;19(2):73-82. doi: 10.1080/10401230701334671. Ann Clin Psychiatry. 2007. PMID: 17612846 Clinical Trial.
-
Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective.Psychol Med. 2006 May;36(5):587-96. doi: 10.1017/S0033291706007239. Psychol Med. 2006. PMID: 16608557
-
Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?J Affect Disord. 2006 Aug;94(1-3):105-10. doi: 10.1016/j.jad.2006.04.002. Epub 2006 Jun 12. J Affect Disord. 2006. PMID: 16766043 Review.
-
Major depression and comorbid substance use disorders.Curr Opin Psychiatry. 2008 Jan;21(1):14-8. doi: 10.1097/YCO.0b013e3282f32408. Curr Opin Psychiatry. 2008. PMID: 18281835 Review.
Cited by
-
Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.Int Clin Psychopharmacol. 2015 Sep;30(5):255-64. doi: 10.1097/YIC.0000000000000081. Int Clin Psychopharmacol. 2015. PMID: 26020712 Free PMC article. Clinical Trial.
-
Agomelatine: The evidence for its place in the treatment of depression.Core Evid. 2010 Jun 15;4:171-9. doi: 10.2147/ce.s6005. Core Evid. 2010. PMID: 20694073 Free PMC article.
-
Cognitive Behavioral Analysis System of Psychotherapy for inpatients with persistent depressive disorder: a naturalistic trial on a general acute psychiatric unit.Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):495-505. doi: 10.1007/s00406-019-01038-5. Epub 2019 Jul 12. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 31300878
-
Persistent depressive disorder across the adult lifespan: results from clinical and population-based surveys in Germany.BMC Psychiatry. 2020 Feb 10;20(1):58. doi: 10.1186/s12888-020-2460-5. BMC Psychiatry. 2020. PMID: 32041560 Free PMC article.
-
Metta-Based Therapy for Chronic Depression: a Wait List Control Trial.Mindfulness (N Y). 2021 Dec;12(12):2929-2942. doi: 10.1007/s12671-021-01753-y. Epub 2021 Oct 8. Mindfulness (N Y). 2021. PMID: 38665227 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical